Quantcast
Last updated on April 18, 2014 at 8:33 EDT

Latest DPT Labs Stories

2013-01-31 12:27:53

RESEARCH TRIANGLE PARK, North Carolina, January 31, 2013 /PRNewswire/ -- KEMWELL BIOPHARMA PVT LTD, a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The cGMP Audit for a Pre-Approval Inspection (PAI) was triggered by a NDA filing by one of the top ten global pharmaceutical companies. This...

2012-08-20 02:30:24

SOLANA BEACH, Calif., Aug. 20, 2012 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs (www.dptlabs.com) to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials. Impracor is the first drug to be developed using Imprimis's...